Free Trial

First Trust Advisors LP Trims Stake in Morgan Stanley $MS

Morgan Stanley logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • First Trust Advisors LP trimmed its Morgan Stanley stake by 36.6% in Q3, selling 307,371 shares and retaining 533,089 shares valued at about $84.74 million.
  • Company insiders have been selling recently — Daniel Simkowitz sold 32,968 shares (~$6.02M) and CFO Sharon Yeshaya sold 15,838 shares (~$2.94M), with insiders offloading 129,191 shares (~$23.74M) over the last 90 days while institutional ownership is 84.19% and insider ownership is 0.19%.
  • Morgan Stanley beat quarterly expectations (EPS $2.68 vs. $2.28; revenue $17.90B), declared a $1.00 quarterly dividend (2.5% yield) and announced ~2,500 job cuts to improve margins, with analysts holding a consensus "Moderate Buy" and an average target of $185.93.
  • Five stocks we like better than Morgan Stanley.

First Trust Advisors LP lessened its position in Morgan Stanley (NYSE:MS - Free Report) by 36.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 533,089 shares of the financial services provider's stock after selling 307,371 shares during the quarter. First Trust Advisors LP's holdings in Morgan Stanley were worth $84,740,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Bedel Financial Consulting Inc. raised its holdings in Morgan Stanley by 2.1% in the third quarter. Bedel Financial Consulting Inc. now owns 3,120 shares of the financial services provider's stock worth $496,000 after purchasing an additional 63 shares in the last quarter. Clear Creek Financial Management LLC grew its position in shares of Morgan Stanley by 2.5% in the 3rd quarter. Clear Creek Financial Management LLC now owns 2,616 shares of the financial services provider's stock worth $416,000 after buying an additional 64 shares during the period. Moss Adams Wealth Advisors LLC grew its position in shares of Morgan Stanley by 0.5% in the 3rd quarter. Moss Adams Wealth Advisors LLC now owns 13,222 shares of the financial services provider's stock worth $2,102,000 after buying an additional 65 shares during the period. Bridgewater Advisors Inc. increased its stake in shares of Morgan Stanley by 1.0% in the 3rd quarter. Bridgewater Advisors Inc. now owns 6,278 shares of the financial services provider's stock worth $1,025,000 after acquiring an additional 65 shares in the last quarter. Finally, Hanson & Doremus Investment Management lifted its position in Morgan Stanley by 8.1% during the 3rd quarter. Hanson & Doremus Investment Management now owns 877 shares of the financial services provider's stock valued at $139,000 after acquiring an additional 66 shares during the period. 84.19% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Daniel A. Simkowitz sold 32,968 shares of the company's stock in a transaction that occurred on Friday, January 30th. The stock was sold at an average price of $182.61, for a total value of $6,020,286.48. Following the transaction, the insider directly owned 357,342 shares of the company's stock, valued at approximately $65,254,222.62. This represents a 8.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Sharon Yeshaya sold 15,838 shares of the stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $185.77, for a total value of $2,942,225.26. Following the sale, the chief financial officer owned 135,304 shares in the company, valued at approximately $25,135,424.08. This represents a 10.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 129,191 shares of company stock worth $23,736,506 over the last 90 days. 0.19% of the stock is currently owned by company insiders.

Key Stories Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

Morgan Stanley Stock Performance

Shares of MS stock opened at $160.70 on Tuesday. Morgan Stanley has a one year low of $94.33 and a one year high of $192.68. The company's 50-day moving average is $177.81 and its 200 day moving average is $168.14. The company has a market capitalization of $255.17 billion, a price-to-earnings ratio of 15.74, a price-to-earnings-growth ratio of 1.29 and a beta of 1.20. The company has a debt-to-equity ratio of 3.39, a quick ratio of 0.81 and a current ratio of 0.81.

Morgan Stanley (NYSE:MS - Get Free Report) last issued its earnings results on Thursday, January 15th. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.28 by $0.40. The business had revenue of $17.90 billion during the quarter, compared to analysts' expectations of $17.69 billion. Morgan Stanley had a net margin of 14.09% and a return on equity of 16.78%. The business's revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.22 earnings per share. Sell-side analysts expect that Morgan Stanley will post 8.56 EPS for the current fiscal year.

Morgan Stanley Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Friday, January 30th were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Friday, January 30th. This represents a $4.00 annualized dividend and a dividend yield of 2.5%. Morgan Stanley's dividend payout ratio (DPR) is 39.18%.

Wall Street Analysts Forecast Growth

MS has been the topic of several research reports. Evercore lowered shares of Morgan Stanley from a "strong-buy" rating to a "hold" rating in a research note on Thursday, February 5th. Wells Fargo & Company raised their target price on shares of Morgan Stanley from $177.00 to $189.00 and gave the company an "equal weight" rating in a research note on Monday, January 5th. Keefe, Bruyette & Woods lifted their target price on shares of Morgan Stanley from $202.00 to $210.00 and gave the company a "moderate buy" rating in a report on Friday, January 16th. The Goldman Sachs Group reissued a "neutral" rating on shares of Morgan Stanley in a research report on Tuesday, January 6th. Finally, Dbs Bank raised Morgan Stanley to a "moderate buy" rating in a research report on Wednesday, November 12th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $185.93.

Read Our Latest Stock Report on Morgan Stanley

Morgan Stanley Company Profile

(Free Report)

Morgan Stanley NYSE: MS is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.

The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.

Featured Articles

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Morgan Stanley Right Now?

Before you consider Morgan Stanley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.

While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines